Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 736,578 | -257,998 | -227,318 | -151,529 | -99,689 |
| Depreciation Amortization | 4,939 | 20,021 | 15,046 | 10,050 | 4,788 |
| Accounts receivable | -42,576 | 17,636 | 29,384 | 56,813 | 103,277 |
| Accounts payable and accrued liabilities | -24,638 | -11,736 | -38,677 | -29,013 | -42,948 |
| Other Working Capital | -78,211 | 80,284 | 36,356 | 81,731 | 53,189 |
| Other Operating Activity | -605,130 | 212,771 | 162,414 | 7,366 | -33,696 |
| Operating Cash Flow | $-9,037 | $60,979 | $-22,795 | $-24,582 | $-15,079 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,026 | -9,600 | -5,954 | -5,723 | -741 |
| Other Investing Activity | 1,122 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-7,904 | $-9,600 | $-5,954 | $-5,723 | $-741 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,042 | -24,843 | -17,678 | -9,709 | -3,230 |
| Common Stock Issued | 37,014 | 98,520 | 83,842 | 29,858 | 14,574 |
| Common Stock Repurchased | -60,693 | -19,682 | -20,334 | -19,748 | -18,327 |
| Other Financing Activity | -9,388 | -12,894 | -13,321 | -12,937 | -12,006 |
| Financing Cash Flow | $-43,109 | $41,102 | $32,508 | $-12,536 | $-18,988 |
| Exchange Rate Effect | 9,464 | -28,559 | -27,664 | -31,512 | -9,039 |
| Beginning Cash Position | 721,014 | 633,067 | 654,050 | 635,193 | 589,479 |
| End Cash Position | 670,429 | 696,989 | 630,145 | 560,841 | 545,632 |
| Net Cash Flow | $-50,586 | $63,922 | $-23,905 | $-74,352 | $-43,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,037 | 60,979 | -22,795 | -24,582 | -15,079 |
| Capital Expenditure | -9,026 | -9,600 | -5,954 | -5,723 | -741 |
| Free Cash Flow | -18,063 | 51,379 | -28,749 | -30,304 | -15,819 |